Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948234 | PMC |
| http://dx.doi.org/10.1073/pnas.1400945111 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Top Ten epilepsy research priorities: A UK priority setting partnership.
Seizure
December 2024
Translational and Clinical Research Institute, Newcastle University, Newcastle, United Kingdom; Royal Victoria Infirmary, Newcastle Hospitals, NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Purpose: Research into epilepsy has experienced decades of chronic underfunding compared to other neurological conditions despite its prevalence and seriousness. To evidence the need for greater investment, the Epilepsy Research Institute (formerly Epilepsy Research UK) funded, led and managed a James Lind Alliance (JLA) Priority Setting Partnership (PSP). This "industry standard" methodology brings together healthcare professionals, patients, carers and patient group representatives to identify and prioritise research uncertainties within a defined area of health or care.
View Article and Find Full Text PDFThe Political Economy of Priority Setting and Resource Allocation in European Oral Health Policy.
JDR Clin Trans Res
December 2024
Department of Dentistry, Quality and Safety of Oral Health Care, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.
Aim: Pressing oral health care challenges pose prioritization dilemmas for governments. This study aimed to identify key determinants of prioritization in oral health policy in Denmark, Germany, the Netherlands, and the United Kingdom, as part of a series of the DELIVER project.
Methods: A literature review based on a search of PubMed and Google Scholar articles related to these countries from January 1, 2000, to October 17, 2023, and key informant interviews with policy makers were conducted to identify key trends in oral health policy choices and determinants of priority setting and resource allocation processes.
Maternal Health Planning and Prioritization in Chad: Developing a supportive tool.
Health Policy Plan
December 2024
Professor Global Health, Department of International Public Health, Liverpool School of Tropical Medicine; Department of Obstetrics and Gynaecology, University of Nairobi, Kenya.
The Republic of Chad has one of the highest rates of maternal mortality in the world. With scarce resources to respond to competing demands, pragmatic evidence-based planning tools are needed to aid planning and support priority setting. This action research aimed to develop a tool to support maternal health (MH) planning and prioritization decisions and identify priority regions/provinces for intervention in Chad based on aggregate MH coverage gap scores (Target-Coverage=Coverage Gap).
View Article and Find Full Text PDFA pharmaceutical policy accident: collision of shareholder capitalism and Chinese state capitalism driving the shortage of an essential antibiotic.
J Pharm Policy Pract
December 2024
Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.
Background: An explosion in a Chinese factory in 2016 caused a global shortage of essential broad-spectrum antibiotic piperacillin-tazobactam. Hitherto, no detailed, policy-relevant analysis has been conducted on this major shortage event. Thus, we aimed to (1) investigate causes; (2) describe supply chain challenges; and (3) uncover policy gaps to support possible mitigation actions.
View Article and Find Full Text PDFThe Future of Health Technology Assessment in Low- and Middle-Income Countries.
Health Syst Reform
December 2023
CGD Europe, Global Health Program, London, UK.
In recent decades, low- and middle-income countries (LMICs) have turned to health technology assessment (HTA) to prioritize health care interventions in pursuit of universal health coverage. HTA has demonstrated its value through significant cost savings, as shown by Thailand and Brazil, where HTA processes facilitated substantial government savings and drug price reductions. Despite these successes, many LMICs still struggle with insufficient capacity to conduct HTA or incorporate its findings into policy decisions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!